Mineralys Therapeutics, Inc.

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC MLYS

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

75,897

Value ($000)

2,754

Weight

0.0%

2025 Q1 - 2025 Q4 (4 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	2,754	0.0%	75,897	12/31/2025
2025 Q3	11/14/2025	2,239	0.0%	59,042	9/30/2025
2025 Q2	8/14/2025	330	0.0%	24,404	6/30/2025
2025 Q1	5/19/2025	124	0.0%	7,800	3/31/2025